Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.4223
+0.0134 (3.28%)
At close: Nov 19, 2026, 4:00 PM EST
0.4220
-0.0003 (-0.07%)
After-hours: Nov 19, 2026, 7:58 PM EST
AKBA's stock price has decreased by -74.41% in the past year and price targets may not have had time to catch up.
Akebia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $2 | Buy | Maintains | $4 → $2 | +373.60% | Nov 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 → $4 | Buy | Reiterates | $6 → $4 | +847.19% | Nov 6, 2026 |
| BTIG | BTIG | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +610.40% | Nov 5, 2026 |
| Westpark Capital | Westpark Capital | Buy Initiates $4.5 | Buy | Initiates | $4.5 | +965.59% | Sep 8, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $1 | Hold | Downgrades | $1 | +136.80% | Aug 7, 2026 |